GRT-R-914

N/A

Report date: 2026/05/13 09:17:22

Base Information

Drug NameGRT-R-914

Drug Alias NamesamRNA-Spikebeta-TCE9samRNA-Spikebeta-TCE-9GRT-R914GRT-R-914

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionCoronavirus spike glycoprotein modulators

TargetsCoronavirus spike glycoprotein

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Africa

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesGritstone Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesGritstone Bio Inc

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A